The Mounjaro Savings Card is Eli Lilly’s copay card for tirzepatide, and on a commercial plan that already covers the drug it can bring your share down to as little as $25 per fill. It works as a secondary payer at the pharmacy counter, which means it lowers a copay; it does not create coverage where none exists.
How the Mounjaro Savings Card Works at the Pharmacy
- Pharmacy bills your insurance first
- Remaining copay is run against the savings card
- Card pays up to its cap ($150/1-month, $300/2-month, $450/3-month)
- You pay the remainder, minimum $25 if under the cap
Three limits decide whether it helps you at all. Your plan has to be private or employer based, the card pays only up to a fixed dollar amount per prescription, and the prescription has to be for the use Mounjaro is approved for. If you have Medicare, Medicaid, TRICARE or VA benefits, or you are paying cash, the card will not apply, and the sections below cover what does.
How the Mounjaro Savings Card works in dollars
The mechanics are simple once you see the order of payment. The pharmacy bills your insurance first. Whatever copay or coinsurance is left is then run against the card, which pays part of that balance up to a ceiling. You pay the remainder, and the floor for eligible patients is $25.
The ceiling is the part people miss. Card savings are capped at up to $150 per 1-month prescription, $300 per 2-month prescription, or $450 per 3-month prescription (Eli Lilly). Below that cap you land at $25. Above it, you pay the overflow.
- Copay of $95 on a one-month fill: the card pays $70, you pay $25.
- Copay of $175: the card pays $150, you pay $25.
- Copay of $400: the card pays its $150 maximum, you pay $250.
- Copay of $500 on a three-month fill: the card pays up to $450, you pay $50.
There is no arbitrage between fill lengths. Three separate one-month fills draw up to $450 in total, the same as one three-month fill. What changes is convenience, how your plan prices a 90-day supply, and how many chances there are for a claim to reject.
If the card lands you at $25 a fill, twelve fills is $300 across the year. If your copay sits above the cap, the number gets uncomfortable fast, so put your real copay in before you plan a year of refills.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
Mounjaro savings card eligibility: who actually qualifies
Eligibility is set by your insurance type and your prescription, not by your pharmacy or your income. The standard requirements look like this:
- You have commercial or private prescription drug coverage, such as an employer plan or a plan bought on the marketplace.
- You have a prescription for the approved use of Mounjaro.
- You are a resident of the United States or Puerto Rico and have reached the age of majority in your state.
- You are not enrolled in any government funded program, including Medicare Part D, Medicare Advantage drug coverage, Medicaid, Medigap, TRICARE, VA or Department of Defense benefits.
- You are not submitting the claim to a state or federal program for reimbursement, and you are not stacking the card with another discount for the same fill.
Two more details are worth reading in the terms. Cards carry an expiration and a maximum benefit period, so the version saved in your wallet app can quietly stop working. And a plan or a state can restrict manufacturer copay support, which is why the card is written as “as little as” $25 rather than a flat price.
Why it matters: the card is a discount on a copay, so if your plan does not cover Mounjaro at all, there is no copay for it to reduce.
Why Medicare and Medicaid patients cannot use it
This is the single most common disappointment, and it is not Lilly being difficult. Federal rules restrict drug manufacturers from paying the cost sharing of patients enrolled in federal health programs, because that kind of payment is treated as an inducement to use a specific product. The result is a hard line: government coverage in, copay card out.
If you have Part D coverage, the useful moves are different ones:
- Pull your plan’s formulary and check the tier, any prior authorization requirement, step therapy rule and quantity limit attached to tirzepatide.
- Ask your prescriber to file a coverage determination, and if it is denied, a tier exception or a formal appeal with your A1c history and prior medicines documented.
- Check whether you qualify for the Low Income Subsidy, often called Extra Help, which reduces Part D cost sharing.
- Use the annual out-of-pocket limit in Part D to your advantage: once you hit it, covered drug costs stop for the rest of the plan year, so a high-cost drug behaves very differently in December than in January.
- Look at independent charitable assistance foundations, which are permitted to help federal beneficiaries. Confirm the drug and the diagnosis are on that foundation’s current list before you count on it.
How to get the card and get it to work at the counter
- Call your plan’s member services and confirm coverage, tier and any prior authorization or step therapy requirement. Do this before you fill.
- Get the card from Lilly’s own savings and coverage site rather than a third-party copy, since older cards and expired terms circulate widely.
- Accept the terms and note the card’s BIN, PCN, group number and member ID. Those four fields are what the pharmacy actually needs.
- Hand the details to the pharmacist and ask them to bill your insurance first and then process the card as secondary coverage.
- Check the receipt. If the amount does not match what the card should pay, ask the pharmacist to reprocess, and if it still looks wrong, call Lilly Support Services at 1-800-545-5979.
Quick tip: ask the pharmacy to run a test claim before they open the box, because once a specialty or refrigerated item is dispensed it usually cannot be returned or reprocessed.
Can you use the Mounjaro savings card at CVS, Walgreens or mail order?
Yes, in most cases. The card is processed like a secondary insurance claim, and the large retail chains and most mail-order and PBM-owned pharmacies handle those claims routinely. Eligibility is decided by your plan type, not by the store sign, so a commercially insured patient can use it at CVS and a Medicare patient cannot use it at CVS.
What usually goes wrong is plumbing rather than policy:
- Your plan may force specialty or 90-day fills through one contracted pharmacy, so the retail claim rejects before the card is ever tried.
- The pharmacy processes the card as primary by mistake, and the price comes back at full retail.
- The card has expired or the annual terms changed, so it needs to be reissued.
- You are trying to combine the card with a separate discount coupon, which the terms do not allow. One path per fill.
Weight loss, no diabetes, and the Zepbound split
Mounjaro is approved to improve blood sugar in adults with type 2 diabetes, alongside diet and exercise. It is not approved for weight management, and it is not for type 1 diabetes. Copay support follows the label, so a prescription written purely for weight loss generally fails both the coverage check and the card check.
The same molecule, tirzepatide, is sold by Lilly as Zepbound for chronic weight management and for obstructive sleep apnea in adults with obesity. Zepbound has its own savings card with its own ceilings: savings are capped at up to $100 per 1-month prescription, $200 per 2-month prescription, or $300 per 3-month prescription (Eli Lilly). If weight is the reason for treatment, that is usually the correct brand and the correct card to be asking about.
Mounjaro vs. Zepbound Savings Card Caps
| Mounjaro (Type 2 Diabetes) | Zepbound (Weight Management) | |
|---|---|---|
| 1-month fill cap | $150 | $100 |
| 2-month fill cap | $300 | $200 |
| 3-month fill cap | $450 | $300 |
Clinically, tirzepatide carries a boxed warning for thyroid C-cell tumors seen in rodent studies, and it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Nausea, diarrhea, vomiting, constipation and reduced appetite are the common side effects, and pancreatitis, gallbladder problems and low blood sugar when combined with insulin or a sulfonylurea are the ones your prescriber will monitor for. Report severe or persistent abdominal pain promptly.
The fine print that quietly eats your savings
Copay cards and health plans are in a running argument about whose money counts. Two plan designs decide how much of the card’s value you actually keep.
A copay accumulator lets the card pay your cost share but does not credit that money toward your deductible or out-of-pocket maximum. You feel cheap at the counter, then hit a full deductible later in the year as if you had paid nothing. A copay maximizer resets your cost share to match the assistance available, so the program is drained on schedule and your own spending never advances. Some employers also route high-cost drugs through alternative funding vendors, which push patients toward manufacturer or charity programs instead of paying the claim.
Two questions get you a straight answer. Ask your benefits administrator whether the plan applies an accumulator or a maximizer to manufacturer copay assistance, and ask for the page of the summary plan description that says so. Then ask whether the drug is classified as a non-essential health benefit under the plan, because that classification is what usually enables a maximizer.
What tirzepatide costs when the card does not apply
Without coverage or a working card, you are looking at list price territory, and Lilly publishes its own price information for Mounjaro. Cash prices then vary by pharmacy, by fill length and by whether you are buying a branded pen or a self-pay route from the manufacturer.
Here is the range across the pricing we track for tirzepatide, rather than a number typed once and left to go stale:
$99 to $399And the cash-pay routes, sorted by price:
No provider matches that filter. .
See every provider we track, with filters and sorting
Compounded tirzepatide is a separate category and not a cheaper version of the same product. Compounded copies are not FDA approved, so their strength, purity and dosing instructions are not reviewed the way a branded pen is. The FDA has flagged safety problems including dosing errors with unapproved GLP-1 products, which is worth weighing before price alone decides.
If the card does not work for you, do these next
- Get the prior authorization filed properly. Most denials for tirzepatide are documentation failures: A1c values, diagnosis coding and prior metformin or other therapy need to be in the submission.
- Appeal in writing if it is denied, then request external review. Plans overturn a meaningful share of their own denials at the second look.
- Ask about a 90-day fill once you are on a stable dose, which reduces claim attempts and can price differently than three monthly fills.
- Price the cash route against your insured cost. If your deductible phase means you pay the full negotiated price anyway, a cash program can be cheaper for those months.
- Compare the routes that work alongside coverage before you switch anything.
No provider matches that filter. .
See every provider we track, with filters and sorting
Value and headline price rarely point at the same option, so it helps to see them side by side:
Best on value
What you get for what you pay.
- Found8.9 / 10
- LillyDirect8.5 / 10
- ShedRx8.2 / 10
- Henry Meds8.2 / 10
- Lumimeds8 / 10
Lowest monthly price
Cheapest verified plan for a new self-pay patient.
- Amazon One Medical$17/mo
- LifeMD$19/mo
- PlushCare$20/mo
- Hims$22/mo
- Strut Health$25/mo
Ranked from our own scores, recomputed as data changes. Providers cannot pay for a place.
If you are deciding between running the drug through your plan or paying cash, do the arithmetic with your own deductible and coinsurance rather than a rule of thumb.
Insurance or cash pay, which is cheaper
Going through insurance is not automatically cheaper. Deductibles, copays and prior authorisation can make a cash-pay programme the better deal.
Coverage is never something a programme can promise: plans decide, prior authorisation is routine for GLP-1 medicines, and denials are common. Confirm with your own plan before choosing.
What to do next
Start with your plan type, because it settles everything else. Commercial coverage means the card is worth activating today and worth checking against an accumulator clause. Government coverage means your energy belongs in formulary checks, exceptions and appeals. No coverage means comparing cash routes and asking whether the diabetes brand or the weight management brand is the right prescription in the first place.
Then write down three numbers before your next refill: your copay, the card cap for your fill length, and what the same medicine costs cash at the pharmacy you use. If the card leaves you above the cash price, you are paying extra for the privilege of using your insurance.
Authoritative sources
- Manufacturer savings and coverage terms
- Manufacturer price information
- Official prescribing information
- Medicare drug coverage rules
- FDA guidance on unapproved GLP-1 products
This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician or pharmacist about your situation, and seek urgent care or call your local emergency number for severe or worsening symptoms.
